TEL AVIV, Israel and OSLO, Norway, July 20, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE

Synergy was demonstrated in a combination arm of GLIX1 and the PARP inhibitor olaparib at low doses,

BioLineRx Ltd. (BLRX) Q1 2026 Earnings Call Transcript

- Announced first patient dosed in Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma

TEL AVIV, Israel and OSLO, Norway, May 22, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE:

Management to Hold Conference Call at 8:30 a.m. EDT TEL AVIV, Israel, May 20, 2026 /PRNewswire/ -- B

New preclinical data further demonstrate GLIX1's robust efficacy in a dose-dependent manner, with st

Patient was dosed at NYU Langone Health under the supervision of Dr. Alexandra Miller, Chief of Neur

OSLO, Norway--(BUSINESS WIRE)--Hemispherian AS, a clinical-stage oncology company developing novel s

GLIX1, a TET2 activator ,  is a first -in- class , oral, small molecule targeting DNA damage respons

BioLineRx Ltd. (BLRX) Q4 2025 Earnings Call Transcript

- On track to initiate Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma (GBM) by end

BioLineRx (NASDAQ: BLRX - Get Free Report) is expected to release its Q4 2025 results before the mar

BioLineRx Ltd. (NASDAQ: BLRX) to release Q4 earnings on March 23. Previous Q3 losses were 22 cents p

Management to Hold Conference Call at 8:30 a.m. EDT TEL AVIV, Israel, March 16, 2026 /PRNewswire/ --

BioLineRx Ltd. ( BLRX ) Q3 2025 Earnings Call November 24, 2025 8:30 AM EST Company Participants Iri

- Establishes joint venture with Hemispherian AS to advance GLIX1, a first-in-class, oral, small mol

Management to Hold Conference Call at 8:30 a.m. EST TEL AVIV, Israel , Nov. 18, 2025 /PRNewswire/ --

Patent covers the use of GLIX1 for treating cancers in which cytidine deaminase (CDA) is not over-ex

BioLineRx Ltd. - Special Call Company Participants Irina Koffler - Managing Director Philip Serlin -

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss

Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earni

Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly

Gainers

  During Thursday's session, 97 companies made new 52-week lows.

  On Friday morning, 446 companies hit new 52-week lows.

  Monday saw 825 companies set new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

Gainers

  Companies Reporting Before The Bell • Boqii Holding (NYSE:BQ) is expected to report quarterly lo

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday.

Gainers Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares jumped 64.2% to $3.4962 on above-aver

    Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs.

    Monday morning saw 558 companies set new 52-week highs.